psalexa

Sleeping Aids Market Research Report: By Offering (Mattresses and Pillows, Sleep Laboratory Services, Medication, Sleep Apnea Devices), Sleep Disorder (Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking) - Global Industry Analysis and Growth Forecast to 2030

  • Published: July 2020
  • Report Code: LS10015
  • Available Format: PDF
  • Pages: 216

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Offering

1.3.2 Market Segmentation by Sleep Disorder

1.3.3 Market Segmentation by Geography

1.3.4 Analysis Period

1.3.5 Market Data Reporting Unit

1.3.5.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Split of Primary Research

2.2.2 Breakdown of Primary Research by Industry Participant

2.2.3 Breakdown of Primary Research by Company Type

2.2.4 Breakdown of Primary Research by Company Revenue and Corporate Designation

2.3 Baseline Methodology

2.4 Market Size Estimation

2.5 Data Triangulation

2.6 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Offering

4.1.1.1 Mattresses and pillows

4.1.1.2 Sleep laboratory services

4.1.1.3 Medication

4.1.1.3.1 Prescription drugs

4.1.1.3.2 OTC drugs

4.1.1.3.3 Herbal remedies

4.1.1.4 Sleep apnea devices

4.1.1.4.1 PAP devices

4.1.1.4.2 Facial interface

4.1.1.4.3 Oral appliances

4.1.1.4.4 ASVs

4.1.1.4.5 Others

4.1.1.5 Others

4.1.2 By Sleep Disorder

4.1.2.1 Insomnia

4.1.2.2 Sleep apnea

4.1.2.3 RLS

4.1.2.4 Narcolepsy

4.1.2.5 Sleep walking

4.1.2.6 Others

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Shifting consumer preference toward herbal OTC drugs

4.2.1.2 Increasing demand for home sleep tests

4.2.1.3 Increased usage of CPAP therapy devices

4.2.2 Drivers

4.2.2.1 Growing prevalence of insomnia and OSA

4.2.2.2 Rising use of portable sleep apnea devices

4.2.2.3 Increasing government support for startup companies

4.2.2.4 Growing network of healthcare facilities

4.2.2.5 Growing adoption of wearable monitors and sensors

4.2.2.6 Surge in demand for sleeping pills, attributed to stressful modern lifestyle

4.2.2.7 Increasing geriatric population

4.2.2.8 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 Long waiting time for sleep care services

4.2.3.2 Shortage of skilled medical professionals

4.2.3.3 Patent expiration of sleep disorder medications

4.2.3.4 Side-effects associated with sleep medications

4.2.3.5 Impact analysis of restraints on market forecast

4.2.4 Opportunities

4.2.4.1 Rising disposable income

4.2.4.2 Increasing patient pool in emerging economies

4.2.4.3 Initiatives by various organizations for increasing awareness

4.3 Porter’s Five Forces Analysis

4.4 Impact of COVID-19

Chapter 5. Global Market Size and Forecast

5.1 By Offering

5.1.1 Sleeping Aid Medication Market, by Type

5.1.2 Sleep Apnea Devices Market, by Type

5.2 By Sleep Disorder

5.3 By Region

Chapter 6. North America Market Size and Forecast

6.1 By Offering

6.1.1 Sleeping Aid Medication Market, by Type

6.1.2 Sleep Apnea Devices Market, by Type

6.2 By Sleep Disorder

6.3 By Country

6.3.1 U.S. Sleeping Aids Market

6.3.1.1 By offering

6.3.1.1.1 Sleeping aid medication market, by type

6.3.1.1.2 Sleep apnea devices market, by type

6.3.1.2 By sleep disorder

6.3.2 Canada Sleeping Aids Market

6.3.2.1 By offering

6.3.2.1.1 Sleeping aid medication market, by type

6.3.2.1.2 Sleep apnea devices market, by type

6.3.2.2 By sleep disorder

Chapter 7. Europe Market Size and Forecast

7.1 By Offering

7.1.1 Sleeping Aid Medication Market, by Type

7.1.2 Sleep Apnea Devices Market, by Type

7.2 By Sleep Disorder

7.3 By Country

7.3.1 Germany Sleeping Aids Market

7.3.1.1 By offering

7.3.1.1.1 Sleeping aid medication market, by type

7.3.1.1.2 Sleep apnea devices market, by type

7.3.1.2 By sleep disorder

7.3.2 U.K. Sleeping Aids Market

7.3.2.1 By offering

7.3.2.1.1 Sleeping aid medication market, by type

7.3.2.1.2 Sleep apnea devices market, by type

7.3.2.2 By sleep disorder

7.3.3 France Sleeping Aids Market

7.3.3.1 By offering

7.3.3.1.1 Sleeping aid medication market, by type

7.3.3.1.2 Sleep apnea devices market, by type

7.3.3.2 By sleep disorder

7.3.4 Italy Sleeping Aids Market

7.3.4.1 By offering

7.3.4.1.1 Sleeping aid medication market, by type

7.3.4.1.2 Sleep apnea devices market, by type

7.3.4.2 By sleep disorder

7.3.5 Spain Sleeping Aids Market

7.3.5.1 By offering

7.3.5.1.1 Sleeping aid medication market, by type

7.3.5.1.2 Sleep apnea devices market, by type

7.3.5.2 By sleep disorder

Chapter 8. APAC Market Size and Forecast

8.1 By Offering

8.1.1 Sleeping Aid Medication Market, by Type

8.1.2 Sleep Apnea Devices Market, by Type

8.2 By Sleep Disorder

8.3 By Country

8.3.1 Japan Sleeping Aids Market

8.3.1.1 By offering

8.3.1.1.1 Sleeping aid medication market, by type

8.3.1.1.2 Sleep apnea devices market, by type

8.3.1.2 By sleep disorder

8.3.2 China Sleeping Aids Market

8.3.2.1 By offering

8.3.2.1.1 Sleeping aid medication market, by type

8.3.2.1.2 Sleep apnea devices market, by type

8.3.2.2 By sleep disorder

8.3.3 India Sleeping Aids Market

8.3.3.1 By offering

8.3.3.1.1 Sleeping aid medication market, by type

8.3.3.1.2 Sleep apnea devices market, by type

8.3.3.2 By sleep disorder

Chapter 9. LATAM Market Size and Forecast

9.1 By Offering

9.1.1 Sleeping Aid Medication Market, by Type

9.1.2 Sleep Apnea Devices Market, by Type

9.2 By Sleep Disorder

9.3 By Country

Chapter 10. MEA Market Size and Forecast

10.1 By Offering

10.1.1 Sleeping Aid Medication Market, by Type

10.1.2 Sleep Apnea Devices Market, by Type

10.2 By Sleep Disorder

10.3 By Country

Chapter 11. Competitive Landscape

11.1 Product Benchmarking of Key Players

11.2 Strategic Developments of Key Players

11.2.1 Product Launches and Approvals

11.2.2 Mergers and Acquisitions

11.2.3 Partnerships, Collaborations and Agreements

11.2.4 Others

Chapter 12. Company Profiles

12.1 Sanofi

12.1.1 Business Overview

12.1.2 Product and Service Offerings

12.1.3 Key Financial Summary

12.2 Merck & Co. Inc.

12.2.1 Business Overview

12.2.2 Product and Service Offerings

12.2.3 Key Financial Summary

12.3 Koninklijke Philips N.V.

12.3.1 Business Overview

12.3.2 Product and Service Offerings

12.3.3 Key Financial Summary

12.4 Pfizer Inc.

12.4.1 Business Overview

12.4.2 Product and Service Offerings

12.4.3 Key Financial Summary

12.5 SleepMed Inc.

12.5.1 Business Overview

12.5.2 Product and Service Offerings

12.6 Cadwell Industries Inc.

12.6.1 Business Overview

12.6.2 Product and Service Offerings

12.7 Natus Medical Incorporated

12.7.1 Business Overview

12.7.2 Product and Service Offerings

12.7.3 Key Financial Summary

12.8 Drive DeVilbiss Healthcare

12.8.1 Business Overview

12.8.2 Product and Service Offerings

12.9 Takeda Pharmaceutical Company Limited

12.9.1 Business Overview

12.9.2 Product and Service Offerings

12.9.3 Key Financial Summary

12.10 Compumedics Limited

12.10.1 Business Overview

12.10.2 Product and Service Offerings

12.10.3 Key Financial Summary

12.11 Tempur Sealy International Inc.

12.11.1 Business Overview

12.11.2 Product and Service Offerings

12.11.3 Key Financial Summary

12.12 GlaxoSmithKline plc

12.12.1 Business Overview

12.12.2 Product and Service Offerings

12.12.3 Key Financial Summary

12.13 Serta Simmons Bedding LLC

12.13.1 Business Overview

12.13.2 Product and Service Offerings

12.14 ResMed Inc.

12.14.1 Business Overview

12.14.2 Product and Service Offerings

12.14.3 Key Financial Summary

12.15 Fisher & Paykel Healthcare Limited

12.15.1 Business Overview

12.15.2 Product and Service Offerings

12.15.3 Key Financial Summary

12.16 Löwenstein Medical GmbH & Co. KG

12.16.1 Business Overview

12.16.2 Product and Service Offerings

12.17 BMC Medical Co. Ltd.

12.17.1 Business Overview

12.17.2 Product and Service Offerings

12.18 SomnoMed Limited

12.18.1 Business Overview

12.18.2 Product and Service Offerings

12.18.3 Key Financial Summary

12.19 BRAEBON Medical Corporation

12.19.1 Business Overview

12.19.2 Product and Service Offerings

Chapter 13. Appendix

13.1 Abbreviations

13.2 Sources and References

13.3 Related Reports

 

LIST OF TABLES

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 GLOBAL SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2019)

TABLE 5 GLOBAL SLEEPING AIDS MARKET, BY OFFERING, $M (2020–2030)

TABLE 6 GLOBAL SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2019)

TABLE 7 GLOBAL SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020–2030)

TABLE 8 GLOBAL SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2019)

TABLE 9 GLOBAL SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020–2030)

TABLE 10 GLOBAL SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2019)

TABLE 11 GLOBAL SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020–2030)

TABLE 12 GLOBAL SLEEPING AIDS MARKET, BY REGION, $M (2014–2019)

TABLE 13 GLOBAL SLEEPING AIDS MARKET, BY REGION, $M (2020–2030)

TABLE 14 NORTH AMERICA SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2019)

TABLE 15 NORTH AMERICA SLEEPING AIDS MARKET, BY OFFERING, $M (2020–2030)

TABLE 16 NORTH AMERICA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2019)

TABLE 17 NORTH AMERICA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020–2030)

TABLE 18 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2019)

TABLE 19 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020–2030)

TABLE 20 NORTH AMERICA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2019)

TABLE 21 NORTH AMERICA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020–2030)

TABLE 22 NORTH AMERICA SLEEPING AIDS MARKET, BY COUNTRY, $M (2014–2019)

TABLE 23 NORTH AMERICA SLEEPING AIDS MARKET, BY COUNTRY, $M (2020–2030)

TABLE 24 U.S. SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2019)

TABLE 25 U.S. SLEEPING AIDS MARKET, BY OFFERING, $M (2020–2030)

TABLE 26 U.S. SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2019)

TABLE 27 U.S. SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020–2030)

TABLE 28 U.S. SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2019)

TABLE 29 U.S. SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020–2030)

TABLE 30 U.S. SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2019)

TABLE 31 U.S. SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020–2030)

TABLE 32 CANADA SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2019)

TABLE 33 CANADA SLEEPING AIDS MARKET, BY OFFERING, $M (2020–2030)

TABLE 34 CANADA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2019)

TABLE 35 CANADA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020–2030)

TABLE 36 CANADA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2019)

TABLE 37 CANADA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020–2030)

TABLE 38 CANADA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2019)

TABLE 39 CANADA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020–2030)

TABLE 40 EUROPE SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2019)

TABLE 41 EUROPE SLEEPING AIDS MARKET, BY OFFERING, $M (2020–2030)

TABLE 42 EUROPE SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2019)

TABLE 43 EUROPE SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020–2030)

TABLE 44 EUROPE SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2019)

TABLE 45 EUROPE SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020–2030)

TABLE 46 EUROPE SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2019)

TABLE 47 EUROPE SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020–2030)

TABLE 48 EUROPE SLEEPING AIDS MARKET, BY COUNTRY, $M (2014–2019)

TABLE 49 EUROPE SLEEPING AIDS MARKET, BY COUNTRY, $M (2020–2030)

TABLE 50 GERMANY SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2019)

TABLE 51 GERMANY SLEEPING AIDS MARKET, BY OFFERING, $M (2020–2030)

TABLE 52 GERMANY SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2019)

TABLE 53 GERMANY SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020–2030)

TABLE 54 GERMANY SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2019)

TABLE 55 GERMANY SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020–2030)

TABLE 56 GERMANY SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2019)

TABLE 57 GERMANY SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020–2030)

TABLE 58 U.K. SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2019)

TABLE 59 U.K. SLEEPING AIDS MARKET, BY OFFERING, $M (2020–2030)

TABLE 60 U.K. SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2019)

TABLE 61 U.K. SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020–2030)

TABLE 62 U.K. SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2019)

TABLE 63 U.K. SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020–2030)

TABLE 64 U.K. SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2019)

TABLE 65 U.K. SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020–2030)

TABLE 66 FRANCE SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2019)

TABLE 67 FRANCE SLEEPING AIDS MARKET, BY OFFERING, $M (2020–2030)

TABLE 68 FRANCE SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2019)

TABLE 69 FRANCE SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020–2030)

TABLE 70 FRANCE SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2019)

TABLE 71 FRANCE SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020–2030)

TABLE 72 FRANCE SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2019)

TABLE 73 FRANCE SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020–2030)

TABLE 74 ITALY SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2019)

TABLE 75 ITALY SLEEPING AIDS MARKET, BY OFFERING, $M (2020–2030)

TABLE 76 ITALY SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2019)

TABLE 77 ITALY SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020–2030)

TABLE 78 ITALY SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2019)

TABLE 79 ITALY SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020–2030)

TABLE 80 ITALY SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2019)

TABLE 81 ITALY SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020–2030)

TABLE 82 SPAIN SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2019)

TABLE 83 SPAIN SLEEPING AIDS MARKET, BY OFFERING, $M (2020–2030)

TABLE 84 SPAIN SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2019)

TABLE 85 SPAIN SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020–2030)

TABLE 86 SPAIN SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2019)

TABLE 87 SPAIN SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020–2030)

TABLE 88 SPAIN SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2019)

TABLE 89 SPAIN SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020–2030)

TABLE 90 APAC SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2019)

TABLE 91 APAC SLEEPING AIDS MARKET, BY OFFERING, $M (2020–2030)

TABLE 92 APAC SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2019)

TABLE 93 APAC SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020–2030)

TABLE 94 APAC SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2019)

TABLE 95 APAC SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020–2030)

TABLE 96 APAC SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2019)

TABLE 97 APAC SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020–2030)

TABLE 98 APAC SLEEPING AIDS MARKET, BY COUNTRY, $M (2014–2019)

TABLE 99 APAC SLEEPING AIDS MARKET, BY COUNTRY, $M (2020–2030)

TABLE 100 JAPAN SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2019)

TABLE 101 JAPAN SLEEPING AIDS MARKET, BY OFFERING, $M (2020–2030)

TABLE 102 JAPAN SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2019)

TABLE 103 JAPAN SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020–2030)

TABLE 104 JAPAN SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2019)

TABLE 105 JAPAN SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020–2030)

TABLE 106 JAPAN SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2019)

TABLE 107 JAPAN SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020–2030)

TABLE 108 CHINA SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2019)

TABLE 109 CHINA SLEEPING AIDS MARKET, BY OFFERING, $M (2020–2030)

TABLE 110 CHINA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2019)

TABLE 111 CHINA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020–2030)

TABLE 112 CHINA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2019)

TABLE 113 CHINA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020–2030)

TABLE 114 CHINA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2019)

TABLE 115 CHINA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020–2030)

TABLE 116 INDIA SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2019)

TABLE 117 INDIA SLEEPING AIDS MARKET, BY OFFERING, $M (2020–2030)

TABLE 118 INDIA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2019)

TABLE 119 INDIA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020–2030)

TABLE 120 INDIA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2019)

TABLE 121 INDIA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020–2030)

TABLE 122 INDIA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2019)

TABLE 123 INDIA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020–2030)

TABLE 124 LATAM SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2019)

TABLE 125 LATAM SLEEPING AIDS MARKET, BY OFFERING, $M (2020–2030)

TABLE 126 LATAM SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2019)

TABLE 127 LATAM SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020–2030)

TABLE 128 LATAM SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2019)

TABLE 129 LATAM SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020–2030)

TABLE 130 LATAM SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2019)

TABLE 131 LATAM SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020–2030)

TABLE 132 LATAM SLEEPING AIDS MARKET, BY COUNTRY, $M (2014–2019)

TABLE 133 LATAM SLEEPING AIDS MARKET, BY COUNTRY, $M (2020–2030)

TABLE 134 MEA SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2019)

TABLE 135 MEA SLEEPING AIDS MARKET, BY OFFERING, $M (2020–2030)

TABLE 136 MEA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2019)

TABLE 137 MEA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020–2030)

TABLE 138 MEA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2019)

TABLE 139 MEA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020–2030)

TABLE 140 MEA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2019)

TABLE 141 MEA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020–2030)

TABLE 142 MEA SLEEPING AIDS MARKET, BY COUNTRY, $M (2014–2019)

TABLE 143 MEA SLEEPING AIDS MARKET, BY COUNTRY, $M (2020–2030)

TABLE 144 SANOFI – AT A GLANCE

TABLE 145 SANOFI – KEY FINANCIAL SUMMARY

TABLE 146 MERCK & CO. INC. – AT A GLANCE

TABLE 147 MERCK & CO. INC. – KEY FINANCIAL SUMMARY

TABLE 148 KONINKLIJKE PHILIPS N.V. – AT A GLANCE

TABLE 149 KONINKLIJKE PHILIPS N.V. – KEY FINANCIAL SUMMARY

TABLE 150 PFIZER INC. – AT A GLANCE

TABLE 151 PFIZER INC. – KEY FINANCIAL SUMMARY

TABLE 152 SLEEPMED INC. – AT A GLANCE

TABLE 153 CADWELL INDUSTRIES INC. – AT A GLANCE

TABLE 154 NATUS MEDICAL INCORPORATED – AT A GLANCE

TABLE 155 NATUS MEDICAL INCORPORATED – KEY FINANCIAL SUMMARY

TABLE 156 DRIVE DEVILBISS HEALTHCARE – AT A GLANCE

TABLE 157 TAKEDA PHARMACEUTICAL COMPANY LIMITED – AT A GLANCE

TABLE 158 TAKEDA PHARMACEUTICAL COMPANY LIMITED – KEY FINANCIAL SUMMARY

TABLE 159 COMPUMEDICS LIMITED – AT A GLANCE

TABLE 160 COMPUMEDICS LIMITED – KEY FINANCIAL SUMMARY

TABLE 161 TEMPUR SEALY INTERNATIONAL INC. – AT A GLANCE

TABLE 162 TEMPUR SEALY INTERNATIONAL INC. – KEY FINANCIAL SUMMARY

TABLE 163 GLAXOSMITHKLINE PLC – AT A GLANCE

TABLE 164 GLAXOSMITHKLINE PLC – KEY FINANCIAL SUMMARY

TABLE 165 SERTA SIMMONS BEDDING LLC – AT A GLANCE

TABLE 166 RESMED INC. – AT A GLANCE

TABLE 167 RESMED INC. – KEY FINANCIAL SUMMARY

TABLE 168 FISHER & PAYKEL HEALTHCARE LIMITED – AT A GLANCE

TABLE 169 FISHER & PAYKEL HEALTHCARE LIMITED – KEY FINANCIAL SUMMARY

TABLE 170 LÖWENSTEIN MEDICAL GMBH & CO. KG – AT A GLANCE

TABLE 171 BMC MEDICAL CO. LTD. – AT A GLANCE

TABLE 172 SOMNOMED LIMITED – AT A GLANCE

TABLE 173 SOMNOMED LIMITED – KEY FINANCIAL SUMMARY

TABLE 174 BRAEBON MEDICAL CORPORATION – AT A GLANCE

 

LIST OF FIGURES

 

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 SPLIT OF PRIMARY RESEARCH BY TYPE

FIG 5 SPLIT OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 SPLIT OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 SPLIT OF PRIMARY RESEARCH BY COMPANY REVENUE AND CORPORATE DESIGNATION

FIG 8 DATA TRIANGULATION APPROACH

FIG 9 GLOBAL SLEEPING AIDS MARKET SUMMARY

FIG 10 PROJECTED GLOBAL AGING POPULATION ABOVE 60 YEARS OF AGE

FIG 11 BARGAINING POWER OF BUYERS

FIG 12 BARGAINING POWER OF SUPPLIERS

FIG 13 INTENSITY OF RIVALRY

FIG 14 THREAT OF NEW ENTRANTS

FIG 15 THREAT OF SUBSTITUTES

FIG 16 GLOBAL SLEEPING AIDS MARKET SNAPSHOT (2019)

FIG 17 GLOBAL SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2030)

FIG 18 GLOBAL SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2030)

FIG 19 GLOBAL SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2030)

FIG 20 GLOBAL SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2030)

FIG 21 MAJOR MARKETS FOR SLEEPING AIDS

FIG 22 GLOBAL SLEEPING AIDS MARKET, BY REGION, $M (2014–2030)

FIG 23 NORTH AMERICA SLEEPING AIDS MARKET SNAPSHOT

FIG 24 NORTH AMERICA SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2030)

FIG 25 NORTH AMERICA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2030)

FIG 26 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2030)

FIG 27 NORTH AMERICA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2030)

FIG 28 NORTH AMERICA SLEEPING AIDS MARKET, BY COUNTRY, $M (2014–2030)

FIG 29 EUROPE SLEEPING AIDS MARKET SNAPSHOT

FIG 30 EUROPE SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2030)

FIG 31 EUROPE SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2030)

FIG 32 EUROPE SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2030)

FIG 33 EUROPE SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2030)

FIG 34 EUROPE SLEEPING AIDS MARKET, BY COUNTRY, $M (2014–2030)

FIG 35 APAC SLEEPING AIDS MARKET SNAPSHOT

FIG 36 APAC SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2030)

FIG 37 APAC SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2030)

FIG 38 APAC SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2030)

FIG 39 APAC SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2030)

FIG 40 APAC SLEEPING AIDS MARKET, BY COUNTRY, $M (2014–2030)

FIG 41 LATAM SLEEPING AIDS MARKET SNAPSHOT

FIG 42 LATAM SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2030)

FIG 43 LATAM SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2030)

FIG 44 LATAM SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2030)

FIG 45 LATAM SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2030)

FIG 46 LATAM SLEEPING AIDS MARKET, BY COUNTRY, $M (2014–2030)

FIG 47 MEA SLEEPING AIDS MARKET SNAPSHOT

FIG 48 MEA SLEEPING AIDS MARKET, BY OFFERING, $M (2014–2030)

FIG 49 MEA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014–2030)

FIG 50 MEA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014–2030)

FIG 51 MEA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014–2030)

FIG 52 MEA SLEEPING AIDS MARKET, BY COUNTRY, $M (2014–2030)

FIG 53 PRODUCT BENCHMARKING OF KEY PLAYERS

FIG 54 SANOFI – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)

FIG 55 MERCK & CO. INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)

FIG 56 KONINKLIJKE PHILIPS N.V. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)

FIG 57 PFIZER INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)

FIG 58 NATUS MEDICAL INCORPORATED – REVENUE SPLIT BY PRODUCT MARKET, PRODUCT CATEGORY, AND GEOGRAPHY (2019)

FIG 59 TAKEDA PHARMACEUTICAL COMPANY LIMITED – REVENUE SPLIT BY GEOGRAPHY (2020)

FIG 60 COMPUMEDICS LIMITED – REVENUE SPLIT BY GEOGRAPHY (2019)

FIG 61 TEMPUR SEALY INTERNATIONAL INC. – REVENUE SPLIT BY GEOGRAPHY (2019)

FIG 62 GLAXOSMITHKLINE PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)

FIG 63 RESMED INC. – REVENUE SPLIT BY PRODUCT AND GEOGRAPHY (2019)

FIG 64 FISHER & PAYKEL HEALTHCARE LIMITED – REVENUE SPLIT BY PRODUCT GROUP AND GEOGRAPHY (2019)

FIG 65 SOMNOMED LIMITED – REVENUE SPLIT BY GEOGRAPHY (2019)

Place An Order
USD 4900 USD 6400 USD 8400
Customized Report Solution

Get a bespoke market intelligence solution

 
We are committed to ensuring the highest level of client satisfaction
Quality Acknowledgement
Quality Acknowledgement

Our dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you

Unmatched Standards
Unmatched Standards

Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights

Reach Us
Reach Us Whenever You Need Us

With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required

Data Security
Complete Data Security

We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws